跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
antidotes
首页
药物
antidotes
antidotes
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME
EP 3824902 A1
申请人: PORTOLA PHARM INC
优先权: 2007
CN
EP
US
14 件公开
US 8268783 B2
申请人: SINHA UMA
优先权: 2010
US
7 件公开
NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN
US 2016002188 A1
申请人: FORMA THERAPEUTICS INC
优先权: 2013
CN
US
WO
8 件公开
Thrombus imaging aptamers and methods of using same
US 10660973 B2
申请人: UNIV DUKE
优先权: 2015
US
WO
7 件公开
COMPOSITIONS AND METHODS RELATED TO NUCLEIC ACID ANTICOAGULANTS
EP 3870707 A4
申请人: UNIV NORTH CAROLINA STATE
优先权: 2018
CN
EP
US
WO
6 件公开
PROHEMOSTATIC PROTEINS FOR THE TREATMENT OF BLEEDING
EP 3744840 A1
申请人: ACADEMISCH ZIEKENHUIS LEIDEN
优先权: 2014
CN
EP
US
6 件公开
ANTICOAGULANT ANTIDOTES
EP 3195876 A1
申请人: BOEHRINGER INGELHEIM INT
优先权: 2010
EP
US
6 件公开
US 2012276123 A1
申请人: VAN RYN JOANNE
优先权: 2012
CN
US
4 件公开
Facially amphilic polymers and oligomers and uses thereof
US 2006041023 A1
申请人: UNIV PENNSYLVANIA
优先权: 2004
US
6 件公开
Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof
US 2005287108 A1
申请人: DEGRADO WILLIAM F
优先权: 2004
CN
US
5 件公开
Preparation and compositions of highly bioavailable zerovalent sulfur and uses thereof
US 8771755 B2
申请人: GOJON-ROMANILLOS GABRIEL
优先权: 2012
CN
US
5 件公开
Unit dose formulation of antidotes for factor Xa inhibitors and methods of using the same
US 9056106 B2
申请人: SINHA UMA
优先权: 2010
US
5 件公开
第 1 / 8 页
上一页
下一页
药物
反馈